Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| United Therapeutics Corporation(UTHR) | 2,760,300 | 2,675,000 | -85,300 | $973.94M | $824.62M | 12.87% | -$149.32M |
| Ascendis Pharma A/SADR(ASND) | 5,103,055 | 5,218,000 | +114,945 | $702.54M | $813.28M | 12.69% | +$110.74M |
| argenx SEADR(ARGX) | 1,238,467 | 1,235,177 | -3,290 | $761.66M | $731.06M | 11.41% | -$30.60M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 2,029,000 | 2,022,222 | -6,778 | $626.09M | $669.82M | 10.46% | +$43.73M |
| Krystal Biotech, Inc.(KRYS) | 2,628,822 | 2,731,000 | +102,178 | $411.83M | $492.40M | 7.69% | +$80.57M |
| Blueprint Medicines Corp | 1,185,000 | 3,850,000 | +2,665,000 | $103.36M | $340.76M | 5.32% | +$237.41M |
| Apellis Pharmaceuticals Inc. COM | 12,222,222 | 12,222,222 | 0 | $390.01M | $267.30M | 4.17% | -$122.71M |
| Avidity Biosciences Inc | 7,500,000 | 7,625,000 | +125,000 | $218.10M | $225.09M | 3.51% | +$6.99M |
| Xenon Pharmaceuticals Inc.(XENE) | 5,666,666 | 5,741,666 | +75,000 | $222.13M | $192.63M | 3.01% | -$29.50M |
| Soleno Therapeutics Inc | 2,525,000 | 2,525,000 | 0 | $113.50M | $180.41M | 2.82% | +$66.91M |
| Kymera Therapeutics, Inc.(KYMR) | 5,150,000 | 6,460,000 | +1,310,000 | $207.18M | $176.81M | 2.76% | -$30.37M |
| Sarepta Therapeutics, Inc.(SRPT) | 2,555,555 | 2,674,835 | +119,280 | $310.73M | $170.71M | 2.66% | -$140.02M |
| Amicus Therapeutics Inc. COM | 23,175,000 | 20,500,000 | -2,675,000 | $218.31M | $167.28M | 2.61% | -$51.03M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 11,111,111 | 11,111,111 | 0 | $208.89M | $141.56M | 2.21% | -$67.33M |
| Vera Therapeutics, Inc.(VERA) | 5,610,000 | 5,701,900 | +91,900 | $237.25M | $136.96M | 2.14% | -$100.29M |
| Merus N V | 2,125,000 | 3,000,000 | +875,000 | $89.36M | $126.27M | 1.97% | +$36.91M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 2,770,100 | 2,770,100 | 0 | $150.00M | $108.23M | 1.69% | -$41.77M |
| Intra-Cellular Therapies Inc | 3,050,000 | 625,000 | -2,425,000 | $254.74M | $82.45M | 1.29% | -$172.29M |
| Alkermes plc(ALKS) | 2,450,000 | 2,450,000 | 0 | $70.46M | $80.90M | 1.26% | +$10.44M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 11,865,000 | 8,700,000 | -3,165,000 | $89.22M | $65.25M | 1.02% | -$23.97M |
| Ocular Therapeutix, Inc.(OCUL) | 8,060,000 | 8,060,000 | 0 | $68.83M | $59.08M | 0.92% | -$9.75M |
| Centessa Pharmaceuticals PlcADR | 0 | 4,050,000 | +4,050,000 | $0 | $58.24M | 0.91% | +$58.24M |
| 89bio Inc | 4,100,000 | 6,350,000 | +2,250,000 | $32.06M | $46.16M | 0.72% | +$14.10M |
| MannKind Corporation(MNKD) | 8,750,000 | 8,750,000 | 0 | $56.26M | $44.01M | 0.69% | -$12.25M |
| Vaxcyte, Inc.(PCVX) | 1,175,000 | 1,000,000 | -175,000 | $96.19M | $37.76M | 0.59% | -$58.43M |
| Tourmaline Bio Inc | 2,222,222 | 2,425,000 | +202,778 | $45.07M | $36.88M | 0.58% | -$8.18M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 830,000 | 830,000 | 0 | $34.92M | $30.05M | 0.47% | -$4.86M |
| Taysha Gene Therapies, Inc.(TSHA) | 19,999,999 | 19,999,999 | 0 | $34.60M | $27.80M | 0.43% | -$6.80M |
| uniQure N.V.(QURE) | 2,175,000 | 2,175,000 | 0 | $38.41M | $23.05M | 0.36% | -$15.36M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 4,345,000 | 4,645,548 | +300,548 | $30.15M | $21.56M | 0.34% | -$8.60M |
| Autolus Therapeutics plcADR(AUTL) | 9,910,642 | 9,910,642 | 0 | $23.29M | $15.36M | 0.24% | -$7.93M |
| Septerna, Inc.(SEPN) | 1,110,000 | 1,337,500 | +227,500 | $25.42M | $7.74M | 0.12% | -$17.67M |
| Whitehawk Therapeutics, Inc.(WHWK) | 2,849,402 | 2,849,402 | 0 | $8.99M | $5.07M | 0.08% | -$3.92M |
| BioMarin Pharmaceutical Inc.(BMRN) | 1,462,500 | 0 | -1,462,500 | $96.13M | $0 | — | -$96.13M |
| CG Oncology, Inc.(CGON) | 700,000 | 0 | -700,000 | $20.08M | $0 | — | -$20.08M |
| Iovance Biotherapeutics, Inc.(IOVA) | 3,500,000 | 0 | -3,500,000 | $25.90M | $0 | — | -$25.90M |
| Kura Oncology, Inc.(KURA) | 2,250,000 | 0 | -2,250,000 | $19.60M | $0 | — | -$19.60M |
| Olema Oncology, Inc.(OLMA) | 1,651,982 | 0 | -1,651,982 | $9.63M | $0 | — | -$9.63M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 1,200,000 | 0 | -1,200,000 | $15.08M | $0 | — | -$15.08M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 2,275,000 | 0 | -2,275,000 | $30.08M | $0 | — | -$30.08M |